Table S1. Databases using for Kaplan Meier analysis for CDCA 2-5, 7, 8 in Kaplan Meier Plotter.
| Dataset | Age | Stage | Grade | For drawing Kaplan-Meier plot (OS) | For drawing Kaplan-Meier plot (PFS) | For drawing Kaplan-Meier plot (PPS) |
|---|---|---|---|---|---|---|
| GSE 9891 | – | Stage I: 24 (8.4%); stage II: 18 (6.3%); stage III: 217 (76.2%); stage IV: 22 (7.7%); unknown: 4 (1.4%) | Grade I: 20 (7.0%); grade II: 99 (34.7%); grade III: 161 (56.5%); unknown: 5 (1.8%) | CDCA2-5, CDCA7-8 | CDCA2-5, CDCA7-8 | CDCA2-5, CDCA7-8 |
| GSE 3149 | – | – | – | CDCA4, CDCA8 | – | – |
| GSE 14764 | Mean: 57; range: 36-81 | Stage I: 8 (1.0%); stage II: 1 (1.3%); stage III: 69 (86.2%); stage IV: 2 (2.5%) | Grade I: 3 (3.8%); grade II: 23 (28.7%); grade III: 54 (67.5%) | CDCA4, CDCA8 | CDCA4, CDCA8 | CDCA4, CDCA8 |
| GSE 15622 | – | – | – | CDCA4, CDCA8 | CDCA4, CDCA8 | CDCA4, CDCA8 |
| GSE 18520 | 61.9±12.7 | Stage III–IV: 53 (100%) | Grade III: 53 (100%) | CDCA2-5, CDCA7-8 | – | – |
| GSE 23554 | – | Stage III–IV: 28 (100%) | Grade I: 2 (7.1%); grade II: 8 (28.6%); grade III: 18 (64.3%) | CDCA4, CDCA8 | – | – |
| GSE 19829 | 63.61±10.51 | Stage II: 2 (4.3%); stage III: 22 (81.4%) Stage IV 4 (14.3%) |
Grade III: 28 (100%) | CDCA2-5, CDCA7-8 | – | – |
| GSE 26712 | – | Stage III–IV: 153 (100%) | Grade III: 153 (100%) | CDCA4, CDCA8 | CDCA4, CDCA8 | – |
| GSE 27651 | – | – | Grade I: 21 (48.8%); grade III: 22 (51.2%) | CDCA2-5, CDCA7-8 | – | – |
| GSE 26193 | – | Stage I: 20 (19.8%); stage II: 11 (10.9%); stage III: 59 (58.4%); stage IV: 11 (10.9%) | Grade I: 7 (6.9%); grade II: 33 (32.7%); grade III: 67 (66.3%) | CDCA2-5, CDCA7-8 | CDCA2-5, CDCA7-8 | CDCA2-5, CDCA7-8 |
| GSE 30161 | 62.57±10.51 | Stage III: 53 (91.4%); stage IV: 5 (8.6%) | Grade I: 2 (3.4%); grade II: 19 (32.8%); grade III: 33 (56.9%); unknown: 4 (6.9%) | CDCA2-5, CDCA7-8 | CDCA2-5, CDCA7-8 | CDCA2-5, CDCA7-8 |
| GSE 63885 | – | Stage II: 1 (1.4%); stage III: 59 (84.3%); stage IV: 10 (14.3%) | Grade II: 8 (11.4%); grade III: 44 (62.9%); grade IV: 18 (25.7%) | CDCA2-5, CDCA7-8 | CDCA2-5, CDCA7-8 | CDCA2-5, CDCA7-8 |
| GSE 51373 | – | Stage II: 5 (18.5%); stage III: 19 (70.4%); stage IV: 3 (11.1%) | / | CDCA2-5, CDCA7-8 | CDCA2-5, CDCA7-8 | – |
| TCGA | 59.74±11.52 | – | Grade I: 6 (1.0%); grade II: 69 (11.8%); grade III: 495 (84.3%); grade IV: 1 (0.2%); unknown: 16 (2.7%) | CDCA4, CDCA8 | CDCA4, CDCA8 | CDCA4, CDCA8 |
OS, overall survival; PFS, progress-free survival; PPS, post-progress survival.